January 4, 2022 01:12 PM EST
Pharma
Marketing

Mar­ket­ingRx roundup: Pfiz­er pro­pos­es New Year's res­o­lu­tions; BMS de­buts TV ad for Zeposia in ul­cer­a­tive col­i­tis

Beth Snyder Bulik

Senior Editor

Pfiz­er pitched some ear­ly New Year’s res­o­lu­tions with Covid-re­lat­ed rules in LinkedIn and Face­book video posts just be­fore the end of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Im­munol­o­gy biotech In­ma­gene to join Nas­daq through re­verse merg­er with what's left of Ike­na

A service from the Financial Times